MilliporeSigma and Waters to Collaborate on Extractables and Leachables Reference Library
- Library will enable analytical labs to identify potential E&L compounds in their samples using instruments from Waters and confirm the identity using MilliporeSigma's Supelco® reference materials
- Collaboration to provide testing labs with unrivalled confidence in their results and enhance consumer safety
Burlington, Massachusetts, February 15, 2022 – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Life Science business sector has entered into a collaboration with Waters Corporation to build and expand an Extractables and Leachables (E&L) Reference Library to include ion mobility measurements. The library will enable analytical labs to identify potential extractables and leachable compounds in their samples by using Waters’ ion mobility-enabled Liquid Chromatography Mass Spectrometry (LC-MS) instruments and then confirming the identity and quantity using Supelco® reference materials.
“Accurate screening for extractables and leachables is imperative to ensuring consumer safety, especially in pharmaceuticals, food packaging, or medical devices,” said Heike Petri, Head of Advanced Analytical and Industrial & Testing, Life Science business sector, Merck KGaA, Darmstadt, Germany. “This collaboration will provide manufacturers with unrivalled confidence in their results, help improve workflow efficiency for labs, and ultimately contribute to consumer safety.”
Under the agreement, Waters will use high-quality analytical standards and Reference Materials from the Life Science business sector to build and expand an E&L library of collision cross-section (CCS) values for Waters’ LC-MS instruments. The library, which will be available for download from the Waters Marketplace (login required), will help to identify E&L compounds, with each addition to the library carefully selected to ensure maximum relevance to users. The library is cross-linked to the Life Science’s business sector online product catalogue to provide users access to reference materials to confirm their results.
About the Life Science business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 28,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck KGaA, Darmstadt, Germany, generated sales of € 22.2 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.
Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.
All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Contact
Rachel Bloom-Baglin
Phone: + 1 978 436-1725
Email: rachel.bloom-baglin@milliporesigma.com
Derniers communiqués de presse
Pour continuer à lire, veuillez vous connecter à votre compte ou en créer un.
Vous n'avez pas de compte ?